Feraheme Injection
NDC Package 59338-775-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Feraheme (ferumoxytol) injection is a medication used to treat "iron-poor" blood (iron deficiency anemia). This formulation utilizes a injection delivery system. Marketed by Amag Pharmaceuticals, Inc, this product is identified by NDC 59338-775 and is authorized under FDA application NDA022180.

Identification & Billing

NDC Package Code
59338-775-01
Package Description
1 VIAL, SINGLE-USE in 1 CARTON / 17 mL in 1 VIAL, SINGLE-USE
Product Code
59338-775
11-Digit Billing Format
59338077501
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Feraheme
Non-Proprietary Name
Ferumoxytol
Substance Name
Ferumoxytol Non-stoichiometric Magnetite
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE 510 mg/17mL
Pharmacologic Class
Usage Information
This medication is used to treat "iron-poor" blood (iron deficiency anemia). Ferumoxytol is a form of injectable iron that is used if you cannot take iron by mouth because of side effects or an unsuccessful response to treatment. It is also used by people who have anemia due to long-term kidney disease. Iron is an important part of your red blood cells and is needed to carry oxygen throughout the body. Many people with kidney disease cannot get enough iron from food and require injections. People with kidney disease may also need extra iron because of blood loss during kidney dialysis treatment.

Regulatory & Marketing

Labeler Name
Amag Pharmaceuticals, Inc
Product Type
Human Prescription Drug
FDA Application #
NDA022180
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-13-2009
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

Q0138
Source: ASP
Ferumoxytol, non-esrd
HCPCS Dosage 1 MG
Units / Pkg 510

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (59338-775). Click a package code to view its specific billing and regulatory data.

59338-775-10
10 VIAL, SINGLE-USE in 1 CARTON / 17 mL in 1 VIAL, SINGLE-USE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59338-775-01 identifies a specific commercial package of 1 vial, single-use in 1 carton / 17 ml in 1 vial, single-use of Feraheme, a human prescription drug labeled by Amag Pharmaceuticals, Inc. This injection is formulated for intravenous use and contains ferumoxytol non-stoichiometric magnetite as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amag Pharmaceuticals, Inc on July 13, 2009. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used to treat "iron-poor" blood (iron deficiency anemia). Ferumoxytol is a form of injectable iron that is used if you cannot take iron by mouth because of side effects or an unsuccessful response to treatment. It is also used by people who have anemia due to long-term kidney disease. Iron is an important part of your red blood cells and is needed to carry oxygen throughout the body. Many people with kidney disease cannot get enough iron from food and require injections. People with kidney disease may also need extra iron because of blood loss during kidney dialysis treatment.

How is this Amag Pharmaceuticals, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59338077501. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59338-775-01
11-Digit CMS (5-4-2)
59338-0775-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.